Global Artemether Market Growth 2025-2031

Global Artemether Market Growth 2025-2031

The global Artemether market size is predicted to grow from US$ 529 million in 2025 to US$ 683 million in 2031; it is expected to grow at a CAGR of 4.4% from 2025 to 2031.

Artemether is a highly effective killing agent in erythrocyte phase of plasmodium. It is used in the treatment of chloroquine falciparum malaria and dangerous malaria.

United States market for Artemether is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Artemether is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Artemether is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Artemether players cover KPC Pharmaceuticals, Shreeji Pharma International, HOFON, Guangzhou Hanfang Pharmaceutical, Ankang ChiaTai Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Artemether Industry Forecast” looks at past sales and reviews total world Artemether sales in 2024, providing a comprehensive analysis by region and market sector of projected Artemether sales for 2025 through 2031. With Artemether sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Artemether industry.

This Insight Report provides a comprehensive analysis of the global Artemether landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Artemether portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Artemether market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Artemether and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Artemether.

This report presents a comprehensive overview, market shares, and growth opportunities of Artemether market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Injectables Artemether
Capsules Artemether
Tablets Artemether

Segmentation by Application:
Hospital
Clinic
Laboratory
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
KPC Pharmaceuticals
Shreeji Pharma International
HOFON
Guangzhou Hanfang Pharmaceutical
Ankang ChiaTai Pharmaceutical

Key Questions Addressed in this Report

What is the 10-year outlook for the global Artemether market?

What factors are driving Artemether market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Artemether market opportunities vary by end market size?

How does Artemether break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.